The struggle to end a millennia-long pandemic: novel candidate and repurposed drugs for the treatment of tuberculosis

BD Edwards, SK Field - Drugs, 2022 - Springer
This article provides an encompassing review of the current pipeline of putative and
developed treatments for tuberculosis, including multidrug-resistant strains. The review has …

The role of novel antibiotics in the Management of Diabetic Foot Infection

E Mougakou, E Mastrogianni, M Kyziroglou… - Diabetes Therapy, 2023 - Springer
Diabetic foot infection is a frequent and potentially life-threatening complication of diabetes
mellitus. Antibiotic treatment is the cornerstone of management of diabetic foot infection but …

In vitro antimicrobial activity comparison of linezolid, tedizolid, sutezolid and delpazolid against slowly growing mycobacteria isolated in Beijing, China

X Yu, F Huo, F Wang, S Wen, G Jiang… - Infection and Drug …, 2021 - Taylor & Francis
Background The antimicrobial activities of some new oxazolidinones against slowly growing
mycobacteria (SGM) have never been well evaluated. Methods We evaluate the in vitro …

[HTML][HTML] Current approach to skin and soft tissue infections. Thinking about continuity of care

RB Hernández, MR Pérez, JF Navarro… - Revista Española de …, 2023 - ncbi.nlm.nih.gov
Skin and soft tissue infections are a common reason for patients seeking inpatient and
outpatient medical care. Surgery is an essential part of managing in many episodes. Careful …

Staph wars: the antibiotic pipeline strikes back

EJA Douglas, M Laabei - Microbiology, 2023 - microbiologyresearch.org
Antibiotic chemotherapy is widely regarded as one of the most significant medical
advancements in history. However, the continued misuse of antibiotics has contributed to the …

Pharmacotherapies for multidrug-resistant gram-positive infections: current options and beyond

S Leone, I Pezone, M Pisaturo… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Infections due to multidrug-resistant organisms (MDRO) are a serious concern
for public health with high morbidity and mortality. Though many antibiotics have been …

Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific …

M Pfaller, RE Mendes, JM Streit… - … and Infectious Disease, 2022 - Elsevier
As bone and joint infections (BJIs) frequently require prolonged, systemic antibiotic use,
tedizolid is an attractive candidate for BJI therapy in adults and children. Tedizolid activity …

[HTML][HTML] Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents …

XC Wei, MF Zhao, HR Lv, X Xiao - Journal of Global Antimicrobial …, 2024 - Elsevier
The objective of this study was to investigate the cumulative fraction of response of various
dosage regimens of tedizolid phosphate against Staphylococcus aureus and Streptococcus …

[HTML][HTML] ANTIMICROBIANOS DE ÚLTIMA GENERACIÓN

A Campaña Burguet - Revista CENIC Ciencias Biológicas, 2023 - scielo.sld.cu
En la actualidad, una de las prioridades de la Organización Mundial de la Salud son las
bacterias resistentes a los antibióticos. Las bacterias tienen una gran capacidad de …

[PDF][PDF] The Struggle toEnd aMillennium-Long Pandemic: Novel Candidate andRepurposed Drugs fortheTreatment ofTuberculosis

BD Edwards, SK Field - researchgate.net
This article provides an encompassing review of the current pipeline of putative and
developed treatments for tuberculosis, including multidrug-resistant strains. The review has …